Ms. Jennie Orr joined AnelleO as a consulting business lead and Board Member in June 2018. Ms. Orr has over 20 of experience in drug development, beginning as a strategy consultant at Monitor Group leading launch strategies for pharmaceuticals and vaccines. She spent 12 years at Liquidia Technologies, Inc. in a variety of business Development, R&D, and strategy roles including Vice President of Product Strategy. Ms. Orr also served as Chief Strategy Officer for Camargo Pharmaceutical, a leading drug development consultancy, with a focus on 505(b)(2) drug development. Most recently, she was Senior Vice President of Medical Devices at Premier Research, a global Clinical Research Organization. Currently, Ms. Orr is Chief Business Officer at Pathfinder Oncology. Jennie received her MBA from Stanford and a BA at Dartmouth.
AnelleO is harnessing the advancements in the speed and scale of 3D printing technology for novel solutions in Women’s Health. AnelleO’s first products are Intravaginal Rings (IVRs), which offer a unique platform for sustained delivery of therapeutics – a non-invasive, self-administered and retrievable platform that can deliver drugs over a period of days to months.
Contact us at: [email protected]
Legal Information:
Conflict of Interest Policy
